Physician Assistant · Brooklyn, NY
NPI
1811240484
Since 2012
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3615 Avenue J, Ph
Brooklyn, NY, 11210
Phone (646) 745-0628
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
4,135 services
Medicare patients, 2024
201
Average age 74
Drug cost, 2024
$1.6M
4,006 prescriptions
Company payments, 2025
$2,473
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nii A Clottey was code J0585 (injection, onabotulinumtoxina, 1 unit), 2,900 times for 11 patients. In total Nii A Clottey billed 4,135 services in 28 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 2,900 | 11 | $4.99 | $14K |
| 99213 Office E&M - Established | Office | 262 | 151 | $66.64 | $17K |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 208 | 44 | $0.43 | $88.79 |
| 95886 Electrical Nerve Conductivity | Office | 132 | 63 | $72.22 | $9,534 |
| 96365 Intravenous Infusion, Hydration | Office | 107 | 45 | $49.52 | $5,299 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 92 | 40 | $0.51 | $47.08 |
| 95910 Electrical Nerve Conductivity | Office | 64 | 61 | $135.01 | $8,641 |
| 99204 Office E&M - New | Office | 52 | 52 | $122.33 | $6,361 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 44 | 44 | $120.01 | $5,280 |
| 93890 Ultrasound - Nonspecific | Office | 44 | 44 | $224.48 | $9,877 |
| 93886 Ultrasound - Nonspecific | Office | 39 | 39 | $161.71 | $6,307 |
| 95816 Neurologic | Office | 34 | 34 | $311.76 | $11K |
| 95992 Treatment - Miscellaneous | Office | 19 | 13 | $30.33 | $576 |
By year: 2023 $69K for 2,312 services; 2024 $99K for 4,135 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nii A Clottey prescribed most often to Medicare patients was Nurtec Odt (Rimegepant Sulfate), with 386 prescriptions and refills. In total Nii A Clottey wrote 4,006 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nurtec Odt Rimegepant Sulfate | 386 | 392 | 89 | $606K |
| Memantine Hcl Generic | 359 | 423 | 80 | $3,654 |
| Gabapentin Generic | 312 | 335 | 89 | $2,003 |
| Emgality Pen Galcanezumab-Gnlm | 178 | 184 | 39 | $123K |
| Ubrelvy Ubrogepant | 173 | 179 | 43 | $241K |
| Qulipta Atogepant | 159 | 169 | 34 | $176K |
| Aimovig Autoinjector Erenumab-Aooe | 153 | 153 | 32 | $110K |
| Donepezil Hcl Generic | 139 | 176 | 33 | $483 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 104 | 132 | 28 | $1,959 |
| Tramadol Hcl Generic | 94 | 94 | 53 | $350 |
| Paroxetine Hcl Generic | 94 | 106 | 33 | $552 |
| Lidocaine Generic | 84 | 88 | 23 | $8,301 |
| Levetiracetam Generic | 83 | 90 | 14 | $2,229 |
| Quetiapine Fumarate Generic | 82 | 84 | 16 | $282 |
| Nortriptyline Hcl Generic | 71 | 79 | 31 | $471 |
Brand drugs: - claims; generic drugs: 2,636 claims; opioid claims: 157.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nii A Clottey $2,473 ($2,473 in general payments such as food, travel and fees) from 21 companies. The largest payer was Pfizer Inc. with $667.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 28 | $667 |
| Abbvie Inc. ABBV | 13 | $303 |
| Lundbeck LLC | 10 | $264 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $187 |
| Axsome Therapeutics, Inc. AXSM | 11 | $162 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $119 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $108 |
| Eisai Inc. 4523.T | 4 | $106 |
| Medtronic, Inc. MDT | 2 | $102 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $95.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.